IGM Biosciences announced that Michael Loberg, Ph.D. has retired from its Board of Directors, including as Chairman, effective October 3 . Loberg has served as a member of the IGM Biosciences Board of Directors since 2015 and as Chairman of the Board since 2018. IGM Biosciences is also pleased to announce the appointment of Elizabeth H.Z. Thompson, Ph.D. to its Board of Directors. Dr. Thompson is an accomplished drug development professional who has been involved in the development of important marketed medicines, most recently as the Executive Vice President of Research and Development at Horizon Therapeutics.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IGMS:
- IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors
- Biotech Alert: Searches spiking for these stocks today
- Down More Than 50%: These 2 ‘Strong Buy’ Stocks Are Too Cheap to Ignore
- IGM Biosciences price target lowered to $26 from $49 at Stifel
- IGM Biosciences price target lowered to $17 from $22 at H.C. Wainwright